Estrogen administration enhances thrombin generation in rats

Thrombosis Research

Volumn 112, Issue 5-6, 2003, Pages 325-328

  Ohashi, Ryota ^a   Sugimura, Motoi ^a   Kanayama, Naohiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Estrogen; Rats; Thrombin

Indexed keywords

ESTROGEN; THROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSOCIATION; BLOOD CLOTTING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ESTROGEN ACTIVITY; FEMALE; NONHUMAN; PLASMA; PRIORITY JOURNAL; RAT;

EID: 1642403667     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2003.11.014     Document Type: Article

References (17)

1. Silverton C.J., Chavkin W., Atrash H.K. Pregnancy-related mortality in New York City, 1980 to 1984: causes of death and associated risk factors. Am. J. Obstet. Gynecol. 164:1991;603-608.
2. Rosendaal F.R. Risk factors for venous thrombotic disease. Thromb. Haemost. 25:1999;610-619.
3. Hemker H.C., Bèguin S. Thrombin generation in plasma: its assessment via the endogenous thrombin potential. Thromb. Haemost. 74:1995;134-138.
4. Wielders S., Manjari M., Jan M., Dirk T.S.R., Jean-Pierre C., Richarad W.K.et al. The routine determination of the endogenous thrombin potential, first results indifferent forms of hyper- and hypocoagulability. Thromb. Haemost. 77:1997;629-636.
5. Duchemin J., Pittet J.L., Tartary M., Bèguin S., Gaussem P., Aiach M. A new assay based on thrombin generation inhibition to detect both protein C and protein S deficiencies in plasma. Thromb. Haemost. 71:1994;331-338.
6. Sugimura M., Kobayashi T., Kanayama N., Terao T. Detection of decreased response to activated protein C during pregnancy by an endogenous thrombin potential-based assay. Semin. Thromb. Haemost. 25:1999;497-502.
7. Gresele P., Momi S., Berrettini M., Nenci G., Schwarts H., Semeraro N.et al. Activated human protein C prevents thrombin-induced thromboembolism in mice. Clin. Invest. 101:1998;667-686.
8. Høibraaten E., Qvigastad E., Armesen H., Larsen S., Wilckstrøm E., Sandsetl P.M. Increased risk of recurrent venous thrombosis during hormone replacement therapy. Thromb. Haemost. 84:2000;961-967.
9. Weiss G. Risk of venous thromboembolism with third-generation oral contraceptives: review. Am. J. Obstet. Gynecol. 180:1999;295-301.
10. Suissa S., Spitzer W.O., Rainville B., Cusson J., Lewis M., Heinemann L. Recurrent use of newer oral contraceptives and the risk of venous thrombosis. Hum. Reprod. 15:2000;817-821.
11. Greer A.I. Thrombosis in pregnancy: maternal and fetal issues. Lancet. 353:1999;1258-1265.
12. Rosendaal F.R. Risk factors for venous thrombosis: prevalence, risk, and interaction. Semin. Hematol. 34:1997;171-187.
13. Eriksson B.I., Carlson S., Halvarsson M., Risberg B., Mattsson C. Antithrombotic effect of two low molecular weight thrombin inhibitors and a low-molecular weight heparin in a caval vein thrombosis model in the rat. Thromb. Haemost. 78:1997;1404-1407.
14. Macdonald C, Gilstrap GR, Gant N, Leveno KJ, Gilstrap CL, Hauth JC, Wenstrom KD. Williams Obstetrics 21th edition. New York: Mcgraw-Hill Medical Publishing Division. pp. 147-149.
15. Razandi M., Pedram A., Levein E. Estrogen signals to the preservation of endothelial cell form and function. Biol. Chem. 275:2000;38540-38546.
16. Cecile M., Nieuwenhuys A., Marion A., Feijge H., Béguin S., Heemskerk J. Monitoring hypercoagulant condition in rat plasma: factors determining the endogenous thrombin potential of tissue factor-activated plasma. Thromb. Haemost. 84:2000;1045-1051.
17. Tans G., Curves J., Middeldorp S., Thomassen C., Meijers J., Prins H.M. et al. A randomized cross-over study on the effects of levenogestrel- and desogestrel-containing oral contraceptives on the anticoaglant pathways. Thromb. Haemost. 84:2000;15-21.